Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2022 17:37 ET | Source: Telix Pharmaceuticals Limited

ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment

MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the “Company”) today announces that ZIRCON (Zirconium in Renal Cancer Oncology,...
December 20, 2021 16:45 ET | Source: Telix Pharmaceuticals Limited

First Patient Dosed in Study of Targeted Alpha Therapy Candidate for Bladder Cancer

MELBOURNE, Australia and NANTES, France, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Nantes-based ATONCO S.A.S. (‘ATONCO’) today announce that...
October 04, 2021 17:34 ET | Source: Telix Pharmaceuticals Limited

First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a first patient has been dosed...
September 13, 2021 18:41 ET | Source: Telix Pharmaceuticals Limited

FDA Approves Phase II Kidney Cancer Therapy Study

MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...